Yahoo Finance • 2 months ago
How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to roughly $277 billion. When Buffett is sitting on that much cash because he can't find appealing investments to bu... Full story
Yahoo Finance • 3 months ago
By most metrics, the stock market is priced at a premium these days. But that doesn't mean bargains can't still be found. Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why th... Full story
Yahoo Finance • 4 months ago
Many investors rightfully identify biotech stocks as being riskier than average, and those stocks certainly have a habit of earning their reputation. Still, there are a few up-and-coming biotechs that have revenue and a clear path to gener... Full story
Yahoo Finance • 5 months ago
CRISPR Therapeutics AG (CRSP) came out with a quarterly loss of $1.49 per share versus the Zacks Consensus Estimate of a loss of $1.37. This compares to loss of $0.98 per share a year ago. These figures are adjusted for non-recurring items... Full story
Yahoo Finance • 5 months ago
Gene editing, in which researchers manipulate patients' genetic code to treat genetic illnesses, has been around for a couple of decades. But it has made incredible progress in the past five years. CRISPR Therapeutics(NASDAQ: CRSP), a mid-... Full story
Yahoo Finance • 5 months ago
Cathie Wood is having another rough year. The largest of the Ark Invest exchange-traded funds is down 14% this year in an otherwise buoyant year for growth investors. The fund is down 72% since peaking in early 2021. As the founder, CEO, a... Full story
Yahoo Finance • 5 months ago
California's giant redwood trees were once tiny sprouts or seeds. Likewise, the world's biggest companies were once much smaller. Trees and companies can grow significantly over time -- at least some of them. Three Motley Fool contributor... Full story
Yahoo Finance • 6 months ago
It hasn't been a stellar year so far for biotech companies. The industry, as measured by the SPDR S&P Biotech ETF, is up just 4% since January, significantly lagging the S&P 500 's nearly 17% gain. Of course, it's not hard to find stocks... Full story
Yahoo Finance • 7 months ago
Cathie Wood is known for two things: picking out innovators that will go on to score a win over the long run, and getting in on these stocks at a great price. The founder and chief executive officer of Ark Invest doesn't mind going against... Full story
Yahoo Finance • 7 months ago
Via her ARK Innovation ETF(NYSEMKT: ARKK), portfolio manager Cathie Wood makes a lot of biotech bets, often on companies that are at the cutting edge of innovation in science and technology. Businesses like that tend to have volatile and t... Full story
Yahoo Finance • 7 months ago
As its shareholders already know, CRISPR Therapeutics (NASDAQ: CRSP) has quite a few opportunities on the table. Between its commercialized medicine, a pipeline that's packed with chances to mint blockbuster drugs, and plenty of financial... Full story
Yahoo Finance • 7 months ago
CRISPR Therapeutics AG -Naimish Patel, M.D., appointed to Chief Medical Officer- -Julianne Bruno, M.B.A., promoted to Chief Operating Officer- ZUG, Switzerland and BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CR... Full story
Yahoo Finance • 8 months ago
In this piece, we will take a look at Cathie Wood's latest investment portfolio and her top ten stock picks. If you want to skip our coverage of Ms. Wood, her investment firm, and the latest stock market news, then you can take a look at C... Full story
Yahoo Finance • 9 months ago
Does a 100% return in less than seven years sound pretty good? Most investors would probably say so. But which stocks are good candidates to achieve such a gain? Three Motley Fool contributors think they've found magnificent stocks that c... Full story
Yahoo Finance • 9 months ago
If you're aiming to add diversification, safety, and growth to your portfolio, look no further; a selection of quality healthcare players could do the trick. I mention diversification because, in the field of healthcare, you'll find a vari... Full story
Yahoo Finance • 9 months ago
Price matters. That's true whether we're talking about cars, houses, laptops, or anything else -- including stocks. Three Motley Fool contributors had price in mind when choosing Axsome Therapeutics(NASDAQ: AXSM), CRISPR Therapeutics(NASD... Full story
Yahoo Finance • 10 months ago
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the eve... Full story
Yahoo Finance • 10 months ago
The biotech industry can be risky and volatile, but there are advantages to investing in companies in this field. Many of them develop lifesaving drugs, the kinds we'll need until we can completely eradicate diseases, which doesn't seem li... Full story
Yahoo Finance • 10 months ago
In this piece, we will take a look at the 13 best short squeeze stocks to buy now. If you want to skip our primer on short squeezing, and some of the greatest short squeezes in history, then you can take a look at the 5 Best Short Squeeze... Full story
Yahoo Finance • 10 months ago
Cathie Wood's success is based on two main things: finding innovators and betting on them for the long term. The founder and chief executive officer of Ark Invest goes for innovators in all areas, from information technology to healthcare,... Full story